Novartis's everolimus wins US panel nod for kidney transplant use
08 December 2009
Sue Sutter
The US
FDA's outside experts have endorsed the efficacy and safety of
Novartis's kinase inhibitor everolimus for the prevention of kidney transplant rejection.
In an 11 to one vote, the cardiovascular and renal drugs advisory panel recommended approval for the prophylaxis of acute rejection in...
Please Login to read the full article.
08 December 2009
Sue Sutter
In an 11 to one vote, the cardiovascular and renal drugs advisory panel recommended approval for the prophylaxis of acute rejection in...
Please Login to read the full article.
RELATED CONTENT
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
